← ANALYST RATINGS · TIPRANKS
Mettler-Toledo (MTD): analyst forecast and price target
Analyst consensus
Hold3 Buy4 Hold1 Sell
Ratings of 8 analysts in the last 3 months · top analysts only12-month forecast
Based on 8 price targets given in the last 3 months, the average target is $1,529, the highest $1,700, the lowest $1,200. The average is −5.8% from the last price of $1,622.
Analyst ratings 19
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI xAi Medical - Diagnostics and ResearchxAI Grok-3 | TipRanks - xAI | $1,806 → $1,852+2.5% | Buy | +14.2% | Reiterated | 17.10.26on TipRanks Oct 16 23:05 | — | |
| AI DeepSeek Medical - Diagnostics and ResearchDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $1,846 → $1,893+2.5% | Buy | +16.7% | Reiterated | 17.10.26on TipRanks Oct 16 23:05 | — | |
| AI OpenAI Medical - Diagnostics and ResearchOpenAI 5.2 | TipRanks - OpenAI | $1,798 → $1,844+2.6% | Buy | +13.7% | Reiterated | 17.10.26on TipRanks Oct 16 23:05 | — | |
| AI Anthropic Medical - Diagnostics and ResearchAnthropic Opus-4.5 | TipRanks - Anthropic | $1,726 → $1,770+2.5% | Hold | +9.1% | Reiterated | 17.10.26on TipRanks Oct 16 23:05 | — | |
| AI Google Medical - Diagnostics and ResearchGemini 3-pro | TipRanks - Google | $1,806 → $1,852+2.5% | Buy | +14.2% | Reiterated | 17.10.26on TipRanks Oct 16 23:05 | — | |
| AI PerPlexity Medical - Diagnostics and ResearchPerPlexity SonarPro | TipRanks - PerPlexity | $1,838 → $1,885+2.6% | Buy | +16.2% | Reiterated | 17.10.26on TipRanks Oct 16 23:05 | — | |
| Casey Woodring★★★★★★★★★★#2489 · hits 62% · avg +8.2% | J.P. Morgan | $1,400 → $1,550+10.7% | Hold | −4.5% | Reiterated | 16.10.26on TipRanks Oct 17 08:14 | +0.1% | ↗ |
| AI xAi Medical - Diagnostics and ResearchxAI Grok-3 | TipRanks - xAI | $1,458 → $1,806+23.9% | Buy | +11.3% | Reiterated | 15.10.26on TipRanks Oct 14 23:05 | — | |
| AI DeepSeek Medical - Diagnostics and ResearchDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $1,490 → $1,846+23.9% | Buy | +13.8% | Reiterated | 15.10.26on TipRanks Oct 14 23:05 | — | |
| AI OpenAI Medical - Diagnostics and ResearchOpenAI 5.2 | TipRanks - OpenAI | $1,452 → $1,798+23.8% | Buy | +10.8% | Reiterated | 15.10.26on TipRanks Oct 14 23:05 | — | |
| AI Anthropic Medical - Diagnostics and ResearchAnthropic Opus-4.5 | TipRanks - Anthropic | $1,394 → $1,726+23.8% | Hold | +6.4% | Reiterated | 15.10.26on TipRanks Oct 14 23:05 | — | |
| AI Google Medical - Diagnostics and ResearchGemini 3-pro | TipRanks - Google | $1,458 → $1,806+23.9% | Buy | +11.3% | Reiterated | 15.10.26on TipRanks Oct 14 23:05 | — | |
| AI PerPlexity Medical - Diagnostics and ResearchPerPlexity SonarPro | TipRanks - PerPlexity | $1,484 → $1,838+23.9% | Buy | +13.3% | Reiterated | 15.10.26on TipRanks Oct 14 23:05 | — | |
| Kallum Titchmarsh★★★★★★★★★★#2647 · hits 58% · avg +9.6% | Morgan Stanley | $1,575 | Hold | −2.9% | Reiterated | 09.10.26on TipRanks Oct 12 09:30 | +0.7%next day +0.9% · 5 days +6.6% | ↗ |
| Michael Ryskin★★★★★★★★★★#1994 · hits 58% · avg +5.1% | Bank of America Securities | $1,505 → $1,690+12.3% | Buy | +4.2% | Reiterated | 09.10.26on TipRanks 08:10 | +0.7%next day +0.9% · 5 days +6.6% | ↗ |
| Luke Sergott★★★★★★★★★★#1255 · hits 49% · avg +9.8% | Barclays | $1,575 → $1,700+7.9% | Buy | +4.8% | Reiterated | 07.10.26on TipRanks 03:55 | +0.3%next day +0.2% · 5 days +5.9% | ↗ |
| Evie Koslosky★★★★★★★★★★#9740 · hits 58% · avg −3.1% | Goldman Sachs | $1,440 → $1,510+4.9% | Hold | −6.9% | Reiterated | 20.09.26on TipRanks Sep 21 08:15 | +1.2%next day +4.2% · 5 days +9.0% | ↗ |
| AI xAi Medical - Diagnostics and ResearchxAI Grok-3 | TipRanks - xAI | $1,618 → $1,458−9.9% | Buy | −10.1% | Reiterated | 11.09.26on TipRanks Sep 10 23:05 | — | |
| AI DeepSeek Medical - Diagnostics and ResearchDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $1,626 → $1,490−8.4% | Buy | −8.2% | Reiterated | 11.09.26on TipRanks Sep 10 23:05 | — | |
| AI OpenAI Medical - Diagnostics and ResearchOpenAI 5.2 | TipRanks - OpenAI | $1,604 → $1,452−9.5% | Buy | −10.5% | Reiterated | 11.09.26on TipRanks Sep 10 23:05 | — | |
| AI Anthropic Medical - Diagnostics and ResearchAnthropic Opus-4.5 | TipRanks - Anthropic | $1,561 → $1,394−10.7% | Hold | −14.1% | Reiterated | 11.09.26on TipRanks Sep 10 23:05 | — | |
| AI Google Medical - Diagnostics and ResearchGemini 3-pro | TipRanks - Google | $1,633 → $1,458−10.7% | Buy | −10.1% | Reiterated | 11.09.26on TipRanks Sep 10 23:05 | — | |
| AI PerPlexity Medical - Diagnostics and ResearchPerPlexity SonarPro | TipRanks - PerPlexity | $1,633 → $1,484−9.1% | Buy | −8.5% | Reiterated | 11.09.26on TipRanks Sep 10 23:05 | — | |
| Unknown Analyst | UBS | $1,650 → $1,460−11.5% | Hold | −10.0% | Initiated | 08.09.26on TipRanks Sep 10 23:05 | −0.9%next day −2.2% · 5 days +1.5% | ↗ |
| Natalya Davies★★★★★★★★★★#4625 · hits 89% · avg +16.4% | Rothschild & Co Redburn | $1,200 | Sell | −26.0% | Initiated | 02.09.26on TipRanks 05:15 | −1.0%next day −1.9% · 5 days −5.4% | ↗ |
| Dan Leonard★★★★★★★★★★#656 · hits 62% · avg +14.1% | RBC Capital | $1,515 | Hold | −6.6% | Initiated | 01.09.26on TipRanks 05:20 | −1.4%next day −1.0% · 5 days −6.3% | ↗ |
| Casey Woodring★★★★★★★★★★#2489 · hits 62% · avg +8.2% | J.P. Morgan | $1,200 → $1,400+16.7% | Hold | −13.7% | Reiterated | 04.08.26on TipRanks Aug 5 08:08 | −2.4%next day −0.9% · 5 days +0.1% | ↗ |
| Kallum Titchmarsh★★★★★★★★★★#2647 · hits 58% · avg +9.6% | Morgan Stanley | $1,275 → $1,450+13.7% | Hold | −10.6% | Assigned | 04.08.26on TipRanks 08:17 | −2.4%next day −0.9% · 5 days +0.1% | ↗ |
| Unknown Analyst | Wells Fargo | $1,225 → $1,450+18.4% | Hold | −10.6% | Assigned | 03.08.26on TipRanks 07:10 | +0.6%next day −2.4% · 5 days −3.2% | ↗ |
| Daniel Arias★★★★★★★★★★#1848 · hits 50% · avg +8.0% | Stifel Nicolaus | $1,400 → $1,600+14.3% | Buy | −1.4% | Reiterated | 03.08.26on TipRanks Jul 31 11:23 | +1.9%next day +0.6% · 5 days −2.6% | ↗ |
| Luke Sergott★★★★★★★★★★#1255 · hits 49% · avg +9.8% | Barclays | $1,300 → $1,575+21.2% | Buy | −2.9% | Reiterated | 03.08.26on TipRanks Jul 31 05:33 | +1.9%next day +0.6% · 5 days −2.6% | ↗ |
| Tycho Peterson★★★★★★★★★★#1097 · hits 57% · avg +9.8% | Jefferies | $1,400 → $1,580+12.9% | Buy | −2.6% | Reiterated | 31.07.26on TipRanks 13:50 | +1.9%next day +0.6% · 5 days −2.6% | ↗ |
| Michael Ryskin★★★★★★★★★★#1994 · hits 58% · avg +5.1% | Bank of America Securities | — | Buy | — | Reiterated | 31.07.26on TipRanks 12:22 | +1.9%next day +0.6% · 5 days −2.6% | ↗ |
| Patrick B Donnelly★★★★★★★★★★#2106 · hits 54% · avg +6.0% | Citi | $1,550 | Buy | −4.5% | Reiterated | 08.07.26on TipRanks Jul 9 05:55 | −3.3%next day +2.3% · 5 days +4.1% | ↗ |
| Vijay Kumar★★★★★★★★★★#2375 · hits 54% · avg +4.8% | Evercore ISI | $1,300 → $1,350+3.8% | Buy | −16.8% | Reiterated | 06.07.26on TipRanks 08:55 | −1.9%next day +0.5% · 5 days +0.6% | ↗ |
| Michael Polark★★★★★★★★★★#2909 · hits 51% · avg +6.5% | Wolfe Research | $1,180 | Hold | −27.3% | Initiated | 01.06.26on TipRanks 16:40 | −1.3%next day +0.6% · 5 days +2.3% | ↗ |
| Catherine Ramsey Schulte★★★★★★★★★★#864 · hits 53% · avg +11.2% | Robert W. Baird | $1,445 → $1,194−17.4% | Hold | −26.4% | Reiterated | 11.05.26on TipRanks 06:55 | −4.3%next day −0.4% · 5 days −0.3% | ↗ |
| No ratings for this filter. | ||||||||
Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst
Best analysts covering Mettler-Toledo
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $1,470 at a price of $1,511 (−2.7%); now: $1,530 at $1,622 (−5.7%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 7 | 6 | 8 | 6 | 6 | 3 |
| Hold | 4 | 5 | 7 | 5 | 7 | 7 |
| Sell | 0 | 0 | 0 | 0 | 1 | 1 |
Earnings and sales forecast
Next report: 05.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $12.12 (from $12.07 to $12.28). Last quarter: $11.46.
Sales
Next quarter’s sales estimate — $1.1B (from $1.1B to $1.1B). Last quarter: $1.0B.
Best top-analyst consensus in the sector · Healthcare
About Mettler-Toledo
- CEO: Patrick K. Kaltenbach
- Employees: 16,600
- 1900 Polaris Parkway, Columbus, OH, 43240, US
- www.mt.com
Mettler-Toledo International Inc. (MTD) is a global enterprise dedicated to the production and provision of precision instruments and related services. The company's operations are strategically organized across five geographical divisions: its domestic U.S. market, Swiss operations, Western European activities, Chinese operations, and an 'Other' segment covering remaining territories. Their extensive product portfolio serves diverse scientific and industrial needs. Within the laboratory sphere, Mettler-Toledo supplies a comprehensive array of equipment, including high-precision balances, advanced liquid handling systems (such as pipetting solutions), automated laboratory reactors, titrators, pH meters, sensors and analyzers for process analytics, instruments for evaluating physical properties, thermal analysis systems, and various other analytical tools. These hardware offerings are complemented by LabX, their proprietary software platform designed for managing and analyzing instrument-generated data. For industrial applications, the company offers robust weighing instruments with associated terminals, automated systems for dimensional measurement and data capture, heavy-duty vehicle scales, specialized industrial software, and a full suite of product inspection technologies. This includes metal detectors, X-ray inspection systems, checkweighers, camera-based imaging equipment, and solutions for track-and-trace. Additionally, Mettler-Toledo provides sophisticated retail weighing solutions, encompassing networked scales and accompanying software, standalone scales, and automated packaging and labeling systems specifically tailored for fresh food items. The company caters to a wide spectrum of clients, including the life sciences sector, independent research organizations, testing laboratories, food and beverage manufacturers, food retailers, chemical, specialty chemical, and cosmetics companies, transportation and logistics firms, metals and electronics industries,
Data from the stock’s TipRanks forecast page, read 38 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗